fluorodeoxyglucose f18 has been researched along with diatrizoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakhshi, S; Dhawan, D; Kumar, R; Malhotra, A; Radhakrishnan, V; Sharma, P; Thulkar, S; Vishnubhatla, S | 1 |
| Fox, JJ; Goldman, DA; Gonen, M; Hricak, H; Kuk, D; Larson, SM; Morris, MJ; Scher, HI; Vargas, HA; Wassberg, C; Wibmer, A | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and diatrizoic acid
| Article | Year |
|---|---|
Pediatric nonlymphoblastic non-Hodgkin lymphoma: baseline, interim, and posttreatment PET/CT versus contrast-enhanced CT for evaluation--a prospective study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Contrast Media; Diatrizoate; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Cross-Sectional Studies; Diatrizoate; Diatrizoate Meglumine; Dihydrotestosterone; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Androgen; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2014 |